Prevail Partners
Overview
Prevail Partners is a private equity firm investing in life sciences companies. The firm focuses on clinical-stage biotech and pharmaceutical companies, providing capital to support the development of therapeutics, preventive treatments, medical devices, and diagnostics. Prevail Partners employs proprietary technologies and services through its affiliate, Prevail InfoWorks, to enhance the success rates of clinical trials for its portfolio companies.
Investment Focus
- Clinical-stage biotech and pharmaceutical companies
- Therapeutics, preventive treatments, medical devices, diagnostics
Portfolio Companies
Get the full list of 54,000+ investors
Prevail Partners and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Prevail Partners
What sectors does Prevail Partners invest in?
Prevail Partners invests in Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in Pennsylvania, United States. Prevail Partners is listed as a private equity in the ConnectSafely investor database.
What stage does Prevail Partners invest at?
Prevail Partners backs companies at Early Stage, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does Prevail Partners invest in?
Prevail Partners invests across United States.
What companies has Prevail Partners invested in?
Prevail Partners's portfolio includes Coologics, Kairos Pharma and TNF Pharmaceuticals.
Last updated · Source: ConnectSafely investor database
